secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUTRO BIOPHARMA, INC. (STRO)
CIK:        0001382101
Form:       8-K
Filed at:   2026-06-08T20:01:05+00:00
Accession:  0001193125-26-261658
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sutro Biopharma stockholders elect three Class II directors and ratify auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- Directors Jane Chung (11.4M for), Connie Matsui (9.7M for), James Panek (9.7M for) elected to three-year terms.
- Ratification of Ernst & Young as auditor for 2026 passed with 13.9M for, 501 against.
- Non-binding advisory vote on named executive officer compensation approved with 11.3M for.
- Broker non-votes totaled 2,540,863 on director election and say-on-pay items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382101/000119312526261658/0001193125-26-261658-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382101/000119312526261658/d116098d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-261658

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer